Another insurance company continues to rate the WVU Cancer Institute Osborn Hematopoietic Malignancy and Transplantation Program as excellent. Highmark Blue Cross Blue Shield in West Virginia recently notified the program that it has received the company’s Blue Distinction Centers for Transplants Designation, which denotes commitment to delivering quality specialty care safely, effectively and cost efficiently. This marks the second consecutive time the Cancer Institute has received the designation from Highmark. “This validates that our program continues to provide superior care,” Sonia Leadmon, oncology quality coordinator at the Cancer Institute Mary Babb Randolph Cancer Center, said.
The health insurer took into consideration patient volume, transplant quality outcomes and additional accreditations the program has previoulsly received from other agencies.
WVU's Office of Health Services Research partnering with Cancer Institute on cervical cancer prevention project
The WVU School of Public Health's Office of Health Services Research is partnering with Stephenie Kennedy-Rea, Ed.D., and the WVU Cancer Institute in a new, five-year effort funded by the National Cancer Institute to reduce health disparities in cervical cancer in Appalachia.
Mark your calendars for an upcoming WVU Health Sciences Center Campus Conversation on campus culture on Tue., June 18 at noon in Room 1905 at the Health Sciences Center.
Employees and covered spouses enrolled on a WVU Medicine medical plan must: 1) Complete the RealAge Test®, 2) Receive a Preventive Exam & 3) Indicate Tobacco Status through mycare.sharecare.com by 10/31/19.